[go: up one dir, main page]

AR132405A1 - Métodos y sistemas para seleccionar biomarcadores basados en metilación del adn para la detección de cáncer colorrectal - Google Patents

Métodos y sistemas para seleccionar biomarcadores basados en metilación del adn para la detección de cáncer colorrectal

Info

Publication number
AR132405A1
AR132405A1 ARP240100917A ARP240100917A AR132405A1 AR 132405 A1 AR132405 A1 AR 132405A1 AR P240100917 A ARP240100917 A AR P240100917A AR P240100917 A ARP240100917 A AR P240100917A AR 132405 A1 AR132405 A1 AR 132405A1
Authority
AR
Argentina
Prior art keywords
colorectal cancer
biomarkers
detection
methods
methylation
Prior art date
Application number
ARP240100917A
Other languages
English (en)
Inventor
Emanuel Martin Campoy
Original Assignee
Consejo Nacional De Investigaciones Cientificas Y Tecn Conicet
Univ Nacional De Cuyo Uncuyo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Nacional De Investigaciones Cientificas Y Tecn Conicet, Univ Nacional De Cuyo Uncuyo filed Critical Consejo Nacional De Investigaciones Cientificas Y Tecn Conicet
Publication of AR132405A1 publication Critical patent/AR132405A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a herramientas bioinformáticas para identificar biomarcadores basados en metilación de ADN y métodos para detectar estos biomarcadores en muestras de sangre de pacientes con cáncer colorrectal (CCR). Por lo tanto, la presente invención proporciona un algoritmo para seleccionar biomarcadores de metilación y un sistema de hemi-sonda para la detección de múltiples biomarcadores de metilación en biopsias líquidas de pacientes con CCR utilizando amplificación basada en enzimas de restricción. La presente invención describe además un panel de detección de cáncer colorrectal que comprende sitios CpG de 15 biomarcadores en base a metilación.
ARP240100917A 2023-04-19 2024-04-11 Métodos y sistemas para seleccionar biomarcadores basados en metilación del adn para la detección de cáncer colorrectal AR132405A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202363460335P 2023-04-19 2023-04-19

Publications (1)

Publication Number Publication Date
AR132405A1 true AR132405A1 (es) 2025-06-25

Family

ID=93153160

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP240100917A AR132405A1 (es) 2023-04-19 2024-04-11 Métodos y sistemas para seleccionar biomarcadores basados en metilación del adn para la detección de cáncer colorrectal

Country Status (2)

Country Link
AR (1) AR132405A1 (es)
WO (1) WO2024220595A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070092883A1 (en) * 2005-10-26 2007-04-26 De Luwe Hoek Octrooien B.V. Methylation specific multiplex ligation-dependent probe amplification (MS-MLPA)
EP3512959B1 (en) * 2016-09-15 2021-08-11 Roche Diagnostics GmbH Methods for performing multiplexed pcr
US12480164B2 (en) * 2018-12-04 2025-11-25 EpiMedTechGlobal (EMTG) DNA methylation biomarkers for early detection of cervical cancer
CN116064815B (zh) * 2019-02-14 2024-12-03 博尔诚（北京）科技有限公司 一种食管癌、胃癌、肠癌、肝癌和/或胰腺癌患癌、癌前筛查组合物及其用途
CN112779334B (zh) * 2021-02-01 2022-05-27 杭州医学院 一种用于前列腺癌早期筛查的甲基化标志物组合及筛选方法

Also Published As

Publication number Publication date
WO2024220595A1 (en) 2024-10-24

Similar Documents

Publication Publication Date Title
Li et al. Circulating tumor DNA methylation detection as biomarker and its application in tumor liquid biopsy: advances and challenges
García-Giménez et al. Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory
Tarabichi et al. Neutral tumor evolution?
Wittenberger et al. DNA methylation markers for early detection of women’s cancer: promise and challenges
Devos et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer
Umetani et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum
Chan et al. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma
Dietrich et al. Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions
Hauser et al. Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study
Jantus-Lewintre et al. Update on biomarkers for the detection of lung cancer
PH12022550372A1 (en) Diagnostic system
Gao et al. Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancer
Campanella et al. Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers
Cree Liquid biopsy for cancer patients: principles and practice
CN112236534A (zh) 用于癌症的非侵入性检测的dna甲基化标志物和其用途
PL1668152T3 (pl) Identyfikacja sygnatury ekspresji genów ERBB2 w rakach sutka
Jensen et al. Enhanced performance of DNA methylation markers by simultaneous measurement of sense and antisense DNA strands after cytosine conversion
Balamurugan et al. Identification of spermatozoa by tissue‐specific differential DNA methylation using bisulfite modification and pyrosequencing
Antunes et al. Forensic discrimination of vaginal epithelia by DNA methylation analysis through pyrosequencing
Marqueta-Gracia et al. Differentially methylated CpG regions analyzed by PCR-high resolution melting for monozygotic twin pair discrimination
JP2015006164A (ja) 大腸癌に関する情報の取得方法、ならびに大腸癌に関する情報を取得するためのマーカーおよびキット
Killian et al. Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome
Shimizu et al. Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin
JP2016015948A (ja) 肺癌に関する情報の取得方法、ならびに肺癌に関する情報を取得するためのマーカーおよびキット
Rendek et al. Current challenges of methylation-based liquid biopsies in cancer diagnostics